Pancreatic Cancer Research

ResearcherSouth Texas Veterans Health Care SystemActive in the last 2 years

Addanki Pratap Kumar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5596-6265; OpenAlex author ID A5000043199; NIH RePORTER profile ID 2100223. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 7)
Trials
0
Grants
3
Labs led
1
Collaborators
13
Papers, trials and grants by year

2011: 1 grant · 2012: none · 2013: none · 2014: 2 papers · 2015: none · 2016: 1 paper, 1 grant · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 grant · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 9

  1. Discovery of a novel STAT3 inhibitor: A potential application for pancreatic cancer treatment. Last author DOI 10.1016/j.biopha.2025.118487↗
  2. Characterization of metabolomic associated with pancreatic cancer patients with overweight and obesity. Last author DOI 10.1016/j.clnu.2025.06.015↗
  3. Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching. Co-author DOI 10.1038/s41419-022-05103-1↗
  4. Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1. Last author DOI 10.1016/j.canlet.2018.01.057↗
  5. Downregulation of STAT3/NF-κB potentiates gemcitabine activity in pancreatic cancer cells. Last author DOI 10.1002/mc.22503↗
  6. Pancreatic cancer: Current status and Challenges. Last author DOI 10.1007/s40495-017-0112-3↗
  7. CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy. Co-author DOI 10.1158/1078-0432.ccr-15-3115↗
  8. Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. Last author DOI 10.1158/1078-0432.ccr-13-1664↗
  9. STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth. Last author DOI 10.18632/oncotarget.1810↗

Grants 3

  1. Therapeutic potential of Palmatine in pancreatic cancer I01BX003876↗
  2. Oxidative stress and programmed death pathways: Cross talk in pancreatic cancer R01AT007448↗
  3. Nexrutine Phellodendron amurense bark extract: Potential use in Pancreatic Cancer R21AT005513↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rita Ghosh · 6 shared papers, 2014–2025 · strength 0.77
  2. James W. Freeman · 4 shared papers, 2014–2022 · strength 0.35
  3. Amanda R. Muñoz · 4 shared papers, 2014–2018 · strength 0.29
  4. Shujie Zhao · 2 shared papers, 2016–2022 · strength 0.24
  5. Xiaoyu Yang · 1 shared paper, 2025 · strength 0.22
  6. Divya Chakravarthy · 3 shared papers, 2014–2018 · strength 0.20
  7. Chen Chen · 1 shared paper, 2022 · strength 0.17
  8. Jingjing Gong · 2 shared papers, 2014–2017 · strength 0.13
  9. Rosa F. Hwang · 1 shared paper, 2018 · strength 0.08
  10. Susan M Fischer · 1 shared paper, 2014 · strength 0.04
  11. Jingjing Gong · 1 shared paper, 2014 · strength 0.04
  12. Huamin Wang · 1 shared paper, 2014 · strength 0.04
  13. Scott Kopetz · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.